辉瑞疫苗

这一决定使加拿大成为世界上首个批准在这一年龄群体使用两剂量辉瑞疫苗的国家。

The decision makes Canada the first country in the world to approve the two-dose Pfizer vaccine for this age group .

以色列卫生部周日报告称，辉瑞疫苗加强针极大地提高了60岁及以上以色列人预防感染和严重疾病的能力。

Israel 's Ministry of Health reported on Sunday that the third shot of Pfizer has greatly improved protection from infection and serious illness among Israelis aged 60 and over .

美国食品和药物管理局宣布，对2000多名12至15岁志愿者的实验结果显示，辉瑞疫苗是安全的，能为青少年提供强有力的保护。

The Food and Drug Administration declared that the Pfizer vaccine is safe and offers strong protection for teens based on testing of more than 2 thousand volunteers ages 12 to 15 .

在西班牙、英国和德国进行的初步研究表明，第一剂接种阿斯利康疫苗，第二剂接种辉瑞疫苗，形成的保护效果与接种两剂辉瑞疫苗一样。

Preliminary studies in Spain , Britain and Germany with an AstraZeneca first dose followed by a Pfizer vaccine proved to develop levels of protection as high as two doses of Pfizer .

这是莫德纳和辉瑞公司的疫苗数据总和。

The tally is for both the Moderna and Pfizer vaccines .

辉瑞公司的疫苗需要在极低的温度下保存，预计这将使智利4000公里长的土地上的疫苗分发工作变得复杂。

Pfizer 's vaccine needs to be kept at extremely low temperatures , which is expected to complicate distribution across Chile 's 4000 km length .

研究显示，辉瑞和阿斯利康等疫苗在接种两剂后对印度变种病毒能产生较高的免疫力，然而单剂的保护力似乎会减弱。

Research suggests that vaccines , such as the Pfizer and AstraZeneca jabs , are highly effective against the Indian variant after two doses , but protection from one dose appears to be reduced .

联合开发mRNA疫苗的一家公司的创始人表示，第一阶段和第二阶段的试验表明，其可以与使用相同技术的辉瑞和莫德纳疫苗相媲美。

The founder of one of the companies that jointly developed the mRNA vaccine says phase I and II trials show it the Pfizer and Moderna vaccines which used the same technology .

辉瑞公司宣布其疫苗对5到11岁的儿童有效。

And Pfizer announced that its vaccine works in children 5 to 11 years old .